#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Leber's congenital amaurosis Non-Hodgkin's lymphoma Transitional cell carcinoma Meningococcal immunisation Ewing's sarcoma metastatic Hypochondroplasia Brain abscess Neonatal alloimmune thrombocytopenia Pelizaeus-Merzbacher disease Short-bowel syndrome Congenital hypotransferrinaemia Craniocerebral injury Liposarcoma recurrent Demyelination Keratosis follicular More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis III Antisynthetase syndrome – Trials in Disease Andersen-Tawil syndrome – Diagnostics Leiomyosarcoma metastatic – Basic Information Methylmalonic acidaemia – Basic Information VEXAS syndrome – Treatment Primary hyperoxaluria Retinitis pigmentosa – Treatment Paroxysmal nocturnal haemoglobinuria – Trials in Disease Ewing’s sarcoma metastatic – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nicotine Resinate Sodium Phenylbutyrate Poloxamer 407 Trabectedin Navtemadlin Gemcitabine Biotin Azd3470 Panobinostat VTX2735 SODIUM Azd8630 GSKVX000000048110 Repotrectinib Adezunap Heparin H2-Receptor Antagonist Glycine Permethrin Bt-001 Bi 1819479 More therapies…

    Learn about Your Condition

    Chronic kidney disease Lymphatic malformation Colon cancer Deafness bilateral Urinary tract infection Adrenocortical carcinoma Chondropathy Cardiac failure chronic Myopia Andersen-Tawil syndrome Hydrocephalus Polymyositis Glucose tolerance impaired Arterial disorder Type V hyperlipidaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Infliximab and Azathioprine for Treating Complex Anal Fistulas in Patients Without Crohn’s Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Anal fistula
    Investigated Drugs:
    • Saline
    • Azathioprine
    • Infliximab
    Denmark

  • Study on Switching from Tacrolimus or Ciclosporin to Belatacept for Adolescents with Kidney Transplants

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Belatacept
    • Ciclosporin
    • Tacrolimus
    Belgium France Germany Italy The Netherlands Spain

  • Study on Methotrexate and Dexamethasone for Infants Under One Year with Acute Lymphoblastic Leukemia

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Cyclophosphamide Monohydrate
    • Mitoxantrone
    • Tioguanine
    Austria Belgium Czechia Denmark Finland France +13

  • Study on Human Serum Albumin and Sodium Chloride for Patients with Liver Cirrhosis and Ascites

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Human Serum Albumin
    • Sodium Chloride
    Belgium Denmark Germany Hungary The Netherlands Slovakia +1

  • Study on the Safety and Effectiveness of SpectraCure P18 System and Verteporfin for Treating Recurrent Prostate Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer recurrent
    Investigated Drugs:
    • Ciprofloxacin
    Germany Sweden

  • Study of Apalutamide and Radiation Therapy for Patients with Low Burden Metastatic Hormone Sensitive Prostate Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Apalutamide
    Italy
Previous Page
1 … 577 578 579 580 581 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!